Related Experiment Video
Updated: May 27, 2026

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
High basal NF-κB activity in nonpigmented melanoma cells is associated with an enhanced sensitivity to vitamin D3
Z Janjetovic1, A A Brozyna, R C Tuckey
1Department of Pathology and Laboratory Medicine, Center for Cancer Research, University of Tennessee Health Science Center, 930 Madison Avenue, Memphis, TN 38163, USA.
Background:
Melanoma is highly resistant to current modalities of therapy, with the extent of pigmentation playing an important role in therapeutic resistance. Nuclear factor-κB (NF-κB) is constitutively activated in melanoma and can serve as a molecular target for cancer therapy and steroid/secosteroid action.
Methods:
Cultured melanoma cells were used for mechanistic studies on NF-κB activity, utilising immunofluorescence, western blotting, EMSA, ELISA, gene reporter, and estimated DNA synthesis assays. Formalin-fixed, paraffin-embedded specimens from melanoma patients were used for immunocytochemical analysis of NF-κB activity in situ.
Results:
Novel 20-hydroxyvitamin (20(OH)D(3)) and classical 1α,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) secosteroids inhibited melanoma cell proliferation. Active forms of vitamin D were found to inhibit NF-κB activity in nonpigmented cells, while having no effect on pigmented cells. Treatment of nonpigmented cells with vitamin D3 derivatives inhibited NF-κB DNA binding and NF-κB-dependent reporter assays, as well as inhibited the nuclear translocation of the p65 NF-κB subunit and its accumulation in the cytoplasm. Moreover, analysis of biopsies of melanoma patients showed that nonpigmented and slightly pigmented melanomas displayed higher nuclear NF-κB p65 expression than highly pigmented melanomas.
Conclusion:
Classical 1,25(OH)(2)D(3) and novel 20(OH)D(3) hydroxyderivatives of vitamin D3 can target NF-κB and regulate melanoma progression in nonpigmented melanoma cells. Melanin pigmentation is associated with the resistance of melanomas to 20(OH)D(3) and 1,25(OH)(2)D(3) treatment.
Insights
Vitamin D derivatives inhibit melanoma cell growth by targeting Nuclear Factor-kappa B (NF-κB) in nonpigmented cells. However, melanin pigmentation in melanoma cells causes resistance to these vitamin D treatments.
Area of Science:
- Oncology
- Dermatology
- Endocrinology
Background:
- Melanoma exhibits significant resistance to conventional therapies.
- Melanin pigmentation plays a crucial role in melanoma's therapeutic resistance.
- Nuclear Factor-kappa B (NF-κB) is constitutively active in melanoma and represents a potential therapeutic target.
Purpose of the Study:
- To investigate the effects of vitamin D secosteroids on melanoma cell proliferation and NF-κB activity.
- To determine the role of pigmentation in melanoma's response to vitamin D therapy.
Main Methods:
- Mechanistic studies using cultured melanoma cells (immunofluorescence, western blotting, EMSA, ELISA, gene reporter, DNA synthesis assays).
- In situ analysis of NF-κB activity in patient melanoma specimens using immunocytochemistry.
Main Results:
- Both 20-hydroxyvitamin D3 (20(OH)D3) and 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) inhibited melanoma cell proliferation.
- Vitamin D inhibited NF-κB activity in nonpigmented melanoma cells but not in pigmented cells.
- Patient data revealed higher NF-κB p65 expression in less pigmented melanomas.
Conclusions:
- Vitamin D3 derivatives (1,25(OH)2D3 and 20(OH)D3) can target NF-κB and modulate melanoma progression in nonpigmented cells.
- Melanin pigmentation confers resistance to these vitamin D treatments in melanoma.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Pigmentation
Melanin occurs in two primary forms: eumelanin that provides black and brown pigment and pheomelanin that provides red color. Dark-skinned individuals produce more melanin than those with pale...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Abnormal Proliferation
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
The Intrinsic Apoptotic Pathway

